CAC 40
7 628,57 -42,77 (-0,56 %) Euro Stoxx 50
4 907,30 -40,43 (-0,82 %) Dow Jones
39 150,33 +15,53 (+0,04 %) EUR/USD
1,0697 -0,0009 (-0,09 %) Gold future
2 334,70 -34,30 (-1,45 %) Bitcoin EUR
59 927,46 -200,25 (-0,33 %)
NeoCore Technology Co., Ltd. (4131.TWO)
NeoCore Technology Co., Ltd.
No. 395, Linsen Road
9F-8 Section 1 Longshan, East District
Tainan 701
Taiwan
886 3 3758 5585
https://www.bio-drchip.com.tw
Secteur(s): Healthcare
Secteur d’activité: Biotechnology
Employés à temps plein:
Description
NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and changed its name to NeoCore Technology Co., Ltd. in July 2023. NeoCore Technology Co., Ltd. was founded in 1987 and is headquartered in Tainan, Taiwan.
Gouvernance d’entreprise
L’ISS Governance QualityScore de NeoCore Technology Co., Ltd. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..
